CymitQuimica logo

JTE-907

CAS:

Ref. 3D-CJ175161

ne
Discontinued

Discontinued product. For inquiries about similar products, please fill out our form or email us at .

JTE-907
Biosynth

    Product Information

    Name:JTE-907
    Controlled Product
    Brand:Biosynth
    Description:JTE-907 is a cannabinoid drug that binds to the CB2 receptor and has been shown to have anti-inflammatory properties in animal models of inflammatory bowel disease. It also has a high affinity for the CB2 receptor, which is expressed in immune cells, and low affinity for the CB1 receptor. JTE-907 has been shown to decrease levels of pro-inflammatory cytokines and increase levels of anti-inflammatory cytokines. The drug also increases angiogenic factors, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), which are important for blood vessel formation. In addition, JTE-907 has been shown to inhibit neuronal activity in vitro and show beneficial effects on biological properties in animals with autoimmune diseases.
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Purity:Min. 95%

    Inquiry about discontinued product: JTE-907

    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.